SMSF trustees should review suspended or delisted holdings before 30 June 2026. Realising these positions will crystallise capital losses (usable against future gains) and simplify fund portfolios ahead of the Division 296 reset.
SMSF trustees should review suspended or delisted holdings before 30 June 2026. Realising these positions will crystallise capital losses (usable against future gains) and simplify fund portfolios ahead of the Division 296 reset.
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
22 May 2026
| Name: | PEPTECH LIMITED (PTD) (This company subsequently changed its name and is now ARANA THERAPEUTICS LIMITED. You should refer to that name for Status.) | ||||||
| Date of Listing: | 23 January 1986 | ||||||
| Subsequent Names: |
| ||||||
| Former Names: |
|
Stock Exchange Status:
This company subsequently changed its name and is now ARANA THERAPEUTICS LIMITED. You should refer to that name for Stock Exchange Status.Legal Status:
This company subsequently changed its name and is now ARANA THERAPEUTICS LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status:
This company subsequently changed its name and is now ARANA THERAPEUTICS LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| Company | FROM | TO |
|---|---|---|
| ARANA THERAPEUTICS LIMITED | 12/11/2007 | |
| PEPTECH LIMITED | 13/09/1996 | 12/11/2007 |
| PEPTIDE TECHNOLOGY LIMITED | 13/09/1996 |
REGISTRY:
Computershare Sydney
Level 4, 44 Martin Place Sydney NSW 2000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail
name changed to Arana Therapeutics Limited | 12/11/2007 |
we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - merge with EvoGenix Limited - this corporate event may appear elsewhere in this company record | 20/08/2007 |
name changed from Peptide Technology Limited | 13/09/1996 |
name changed to Arana Therapeutics Limited | 12/11/2007 |
we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - merge with EvoGenix Limited - this corporate event may appear elsewhere in this company record | 20/08/2007 |
name changed from Peptide Technology Limited | 13/09/1996 |
Your browser may reflect a date of printing in American format.
I had Peptech share till 2005 .can you tell me if it still viable .Thank you Wendy c Barnes | 31/01/2018 17:25:51 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Melvyn Bridges | Non Exec Chairman | |
| John Chiplin | Managing Director, CEO | |
| Niall Henderson | CFO, Company Secretary | |
| Gregory Bundy | Independent Director | |
| Martin Kriewaldt | Independent Director | 24/10/2003 |
| William Bartlett | Independent Director | |
| Till Medinger | Non Exec Director | |
| Phil Jennings | Executive Director |
Date of first appointment, title may have changed.
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2026 Investogain Pty Limited. All rights reserved.